Previous 10 | Next 10 |
2024-03-19 10:23:08 ET More on Acurx Pharmaceuticals Acurx Sell-Off Presents Opportunity Before Upcoming Data Release Acurx stock plunges 26% amid Phase 2 data release for C. diff drug Read the full article on Seeking Alpha For further details see: Acurx ...
2024-03-19 10:00:51 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Johnson & Johnson, Boston...
2024-03-18 11:19:09 ET Acurx Pharmaceuticals, Inc. (ACXP) Q4 2023 Earnings Conference Call March 18, 2024 08:00 AM ET Company Participants Robert Shawah - CFO David Luci - President and CEO Robert DeLuccia - Executive Chairman Conference Call Participants ...
2024-03-18 11:15:57 ET More on Acurx Pharmaceuticals Acurx Sell-Off Presents Opportunity Before Upcoming Data Release Acurx stock plunges 26% amid Phase 2 data release for C. diff drug ELAB, KIND and RLX among pre-market losers Seeking Alpha’s Quant Ra...
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update PR Newswire STATEN ISLAND, N.Y. , March 18, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a clini...
Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update PR Newswire STATEN ISLAND, N.Y. , March 4, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP...
Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development PR Newswire As previously announced, planning is underway with FDA to advance ibezapo...
NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) -- FMW Media Work announces that its "New to The Street Leadership," Powered by Sector SPDR ETFs , will air on Bloomberg TV as sponsored programming on Saturday, February 24, 2024, at 6:30 PM ET, and the "New to The Street" business show will air o...
NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television production, announces airing Episode 556 on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT. New to The Street's Episode 556 line-up...
NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street is airing its national TV show on the FOX Business Network on Monday, February 5, 2024, at 10:30 PM. New to The Street's 553rd episode features the following five (5) corporate interviews: 1). Vacation...
News, Short Squeeze, Breakout and More Instantly...
Acurx Pharmaceuticals Inc. Company Name:
ACXP Stock Symbol:
NASDAQ Market:
Acurx Pharmaceuticals Inc. Website:
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces the broadcasting of its national business TV show airing on Bloomberg TV as sponsored programming tonight, Thursday, June 6, 2024, at 9:30 PM PT. New to The Street's TV episode 576 will air the follo...
Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection PR Newswire Agreement with FDA reached on key elements to move forward with our international Phase 3 clinical trial program Agreement al...
Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update PR Newswire STATEN ISLAND, N.Y. , May 15, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a clinical stage biophar...